Mapping the interaction sites of human and avian influenza A viruses and complement factor H

Front Immunol. 2024 Apr 18:15:1352022. doi: 10.3389/fimmu.2024.1352022. eCollection 2024.

Abstract

The complement system is an innate immune mechanism against microbial infections. It involves a cascade of effector molecules that is activated via classical, lectin and alternative pathways. Consequently, many pathogens bind to or incorporate in their structures host negative regulators of the complement pathways as an evasion mechanism. Factor H (FH) is a negative regulator of the complement alternative pathway that protects "self" cells of the host from non-specific complement attack. FH has been shown to bind viruses including human influenza A viruses (IAVs). In addition to its involvement in the regulation of complement activation, FH has also been shown to perform a range of functions on its own including its direct interaction with pathogens. Here, we show that human FH can bind directly to IAVs of both human and avian origin, and the interaction is mediated via the IAV surface glycoprotein haemagglutinin (HA). HA bound to common pathogen binding footprints on the FH structure, complement control protein modules, CCP 5-7 and CCP 15-20. The FH binding to H1 and H3 showed that the interaction overlapped with the receptor binding site of both HAs, but the footprint was more extensive for the H3 HA than the H1 HA. The HA - FH interaction impeded the initial entry of H1N1 and H3N2 IAV strains but its impact on viral multicycle replication in human lung cells was strain-specific. The H3N2 virus binding to cells was significantly inhibited by preincubation with FH, whereas there was no alteration in replicative rate and progeny virus release for human H1N1, or avian H9N2 and H5N3 IAV strains. We have mapped the interaction between FH and IAV, the in vivo significance of which for the virus or host is yet to be elucidated.

Keywords: avian influenza; complement; entry inhibitor; factor H; human influenza; influenza A virus; pseudotype.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Binding Sites
  • Birds / virology
  • Complement Factor H* / immunology
  • Complement Factor H* / metabolism
  • Hemagglutinin Glycoproteins, Influenza Virus* / immunology
  • Hemagglutinin Glycoproteins, Influenza Virus* / metabolism
  • Host-Pathogen Interactions / immunology
  • Humans
  • Influenza A Virus, H3N2 Subtype / immunology
  • Influenza A Virus, H9N2 Subtype / immunology
  • Influenza A virus* / immunology
  • Influenza A virus* / physiology
  • Influenza in Birds / immunology
  • Influenza in Birds / metabolism
  • Influenza in Birds / virology
  • Influenza, Human* / immunology
  • Influenza, Human* / metabolism
  • Influenza, Human* / virology
  • Protein Binding*

Substances

  • Complement Factor H
  • Hemagglutinin Glycoproteins, Influenza Virus
  • CFH protein, human

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work described herein was funded by the Iraqi Ministry of Higher Education and Scientific Research and the University of Basrah, Iraq PhD studentship scholarship to IR and BBSRC ISP Grant BBS/E/I/00007038 & BBS/E/I/00007034 to the Pirbright Institute. UK acknowledges funding via an UAEU UPAR grant (#12F061:2024-2027). The funders had no role in study design, data collection, data interpretation, or the decision to submit the work for publication.